Issue 38: PTAB Trial Tracker | Goodwin

Fate of Fintiv - As discussed in our Client Alert, “Fintiv 2.0: USPTO Director Issues Guidance Softening Risk of Discretionary Denial,” USPTO Director Kathi Vidal issued...

Related Keywords

United States ,Kansas ,Palo Alto ,Texas ,Steven Wagner ,Samsung Iprs ,S David Kimball ,Kathi Vidal ,Staton Techiya ,Daichii Sankyo ,Seth Manilove ,Kansas State University Research Foundation ,Summer Associates Daniel Farraye ,Opensky Industries ,Cardiovalve Ltd ,Boehringer Ingelheim Animal Health United States Inc ,Impinj Inc ,Palo Alto Networks Inc ,Astrazeneca Pharmaceuticals ,Big Beings United States Pty Ltd ,Samsung ,United States Inc ,Alzheon Inc ,Incyte Corp ,Patent Quality Assurance ,Risen Shuzhou Pharma Tech Co ,Qualcomm ,Lb Online Export Pty Ltd ,Intel ,Kansas State University ,Impinij Inc ,See Samsung Electronics Co Ltd ,Seagen Inc ,Us Supreme Court ,Edwards Lifesciences Corp ,Concert Pharmaceuticals Inc ,Bright Data Ltd ,Lbean Inc ,Client Alert ,Issues Guidance Softening Risk ,Discretionary Denial ,Eastern District ,Interim Fintiv Guidance ,Patent Owner ,Director Vidal ,Director Reviews ,Petitioner Opensky ,Director Review ,Beings United States Pty ,Export Pty ,Deam Online ,Big Beings United States Pty ,Nested Bean ,Big Beings ,Patent Act ,Ingelheim Animal Health United States ,State University Research Foundation ,Director Iancu ,Federal Circuit ,Data Ltd ,General Plastics ,Palo Alto Networks ,Edwards Lifesciences ,Under Rule ,Associates Daniel Farraye ,